AMP Capital becomes Collimate Capital
AMP Capital has announced it will rebrand as Collimate Capital to reflect the new direction following its demerger from AMP Limited.
The new business would be rebranded as Collimate when it would be listed on the Australian Securities Exchange (ASX) in the second half of this year. It said its change symbolised an ongoing progress towards demerging.
In the announcement, the firm also said that the business had progressed well in operating separately from AMP Limited and had its own executive leadership team, board and strategy, with Patrick Snowball announced as chairman designate and Andrew Fay as deputy chairman designate of the demerged business in October last year.
Prior to that, in June, 2021, Shawn Johnson joined as AMP Capital’s chief executive to lead the demerger of the business and in January, 2022, Nadine Lennie was announced as chief financial officer.
The appointment of Johnson followed the departure of Boe Pahari as AMP Capital chief executive in August 2020 after a sexual allegation.
Commenting on the new name, Johnson said that Collimate Capital, as a demerged entity, would provide a greater level of independence, stability and accountability.
“Collimate is a scientific term that means to make rays of light perfectly parallel. It is a metaphor for alignment, clarity and precision, which speaks to our vision and expertise in long-term value creation for our clients,” the company said in the announcement.
Recommended for you
Some 42 per cent of CEOs say they are actively reinventing their business to stay relevant in the next decade, with consumer services the most common choice for asset and wealth managers.
Former Ophir Asset Management chief executive, George Chirakis, has joined private equity manager Scarcity Partners, while the asset manager has appointed a replacement from Macquarie.
Australian Unity has appointed a fund manager for its Healthcare Property Trust, joining from Centuria Healthcare, as it restructures the product with a series of senior appointments.
Financial advisers nervous about the liquidity of private markets funds for their retail clients are the target of fund managers launching semi-liquid products which offer greater flexibility and redemptions.